NFKB1 and Stroke: Its suppression of neuroinflammation via inhibition of the NF-κB and Toll-like receptor 4 signaling pathways in BV2 microglia suggests relevance in reducing post-stroke neuroinflammatory responses, which are closely linked to depressive symptoms [146].